Boner A L, Vallone G, Nardi M, Miglioranzi P, Gaburro D
Ann Allergy. 1986 Nov;57(5):367-70.
Two different methods of performing specific bronchial challenge using a micronized freeze-dried extract of D. pteronyssinus administered as a powder by a spinhaler have been evaluated in 11 children with chronic asthma and skin test RAST positive for house dust mite D. pteronyssinus. In the first method, "Cumulative Dose Method" (CDM), the test doses of antigen [0, 50, 100, 200, 400, 600, 800, and 1,000 Allergenic Units (A.U.)] were successively administered in 30-minute intervals. With the other method, "Daily Increasing Dose Method" (DIDM), a single antigen challenge (only one cup) was performed every day successively. The tests were considered positive when FEV1 values dropped below 20% of the value obtained immediately before the inhalation of the antigen. The early FEV1 fall was 36.6% +/- 10.8% with CDM and 29.1% +/- 11.5% with DIDM. There was a mean late fall of FEV1 52% +/- 17% and 35.3% +/- 12.2%, respectively, after a mean antigen administration of 270 +/- 149 A.U. with CDM and of 290 +/- 202 A.U. with DIDM. An increase in non-specific bronchial reactivity was observed after specific challenge performed with both methods. The CDM offers the advantage of obtaining information more quickly. The DIDM offers the advantage of administering a lower daily dose of antigen. Our results indicate that a modification of CDM with a shorter interval of administration may further improve this method of antigen administration.
对于11名患有慢性哮喘且对屋尘螨粉尘螨皮肤试验RAST呈阳性的儿童,评估了两种使用自旋雾化器以粉末形式给予的微粉化冻干粉尘螨提取物进行特异性支气管激发试验的不同方法。在第一种方法“累积剂量法”(CDM)中,抗原的试验剂量[0、50、100、200、400、600、800和1000变应原单位(A.U.)]以30分钟的间隔依次给予。在另一种方法“每日递增剂量法”(DIDM)中,每天依次进行单次抗原激发(仅一杯)。当FEV1值降至吸入抗原前即刻获得的值的20%以下时,试验被视为阳性。CDM时早期FEV1下降为36.6%±10.8%,DIDM时为29.1%±11.5%。在CDM平均给予抗原270±149 A.U.和DIDM平均给予抗原290±202 A.U.后,FEV1平均后期下降分别为52%±17%和35.3%±12.2%。用这两种方法进行特异性激发试验后均观察到非特异性支气管反应性增加。CDM的优点是能更快获得信息。DIDM的优点是每日给予的抗原剂量较低。我们的结果表明,缩短给药间隔对CDM进行改进可能会进一步改善这种抗原给药方法。